Delivery Order SPE2DB22D2206-SPE2DB25FHC94
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TAVNEOS 10 mg capsules (180-count units) on September 17, 2025, with a ceiling value of $10,218.17 and completion deadline of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAVNEOS 10 MG CAPSULE 180S, a pharmaceutical product, with a ceiling value of $10,218.17. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award date is May 28, 2025, and the ultimate completion date is June 18, 2025. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...
- This delivery order, awarded on September 15, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is valued at $10,532.44 under a firm fixed-price arrangement with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $10,447.93 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is categorized as a competitive award,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $10,330.72 from the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under the company's broader Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award carries no...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,740 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 18, 2025, with completion scheduled for June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,634.38 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price contract, awarded on July 14, 2025, with an ultimate completion date of July 14, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award involved no set-aside designation,...
- The Defense Logistics Agency awarded a $27,926.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALVEY 40 mg/mL vials, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award, issued on August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,866.35 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025. This non-set-aside contract, which has an ultimate completion date of July 28, 2025, represents a child award under a larger indefinite delivery contract vehicle. The delivery order calls for pharmaceutical products and medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHC94Delivery Order
The Defense Logistics Agency awarded a $10,218.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Tavneos 10 mg, a pharmaceutical product for federal medical procurement needs. The contract is non-set-aside and competitively awarded, with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of June 17, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Health Agency and military healthcare systems. The company's SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the company's role in fulfilling federal medical supply requirements through the DLA's established procurement framework for pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 5/27/25 |